A 32-year-old man presents to the outpatient clinic with a 2-month history of persistent sadness, profound fatigue, early morning awakening, and difficulty concentrating at work. He reports that his symptoms have led to a recent poor performance review. He denies suicidal ideation, psychotic symptoms, or active medical problems. Physical examination and baseline laboratory studies are unremarkable. You suspect major depressive disorder (MDD) and plan to initiate treatment. Arrange the following clinical management steps in the most appropriate chronological sequence, assuming the patient eventually requires treatment escalation due to an initial inadequate response.
- 1Screen for a lifetime history of manic or hypomanic episodes.
- 2Initiate monotherapy with a first-line antidepressant, such as a selective serotonin reuptake inhibitor (SSRI).
- 3Reassess the patient's symptom severity and medication tolerability in 4 to 6 weeks.
- 4Augment the current regimen with a medication from a different class or switch to an alternative agent.
Cevap
The correct sequence is to first screen for bipolar disorder, then initiate an SSRI, follow up in 4-6 weeks to assess efficacy, and finally augment or switch if the initial trial is unsuccessful.
The standard sequence for managing a new presentation of major depressive disorder begins with diagnostic safety—specifically, screening for a history of mania or hypomania to rule out bipolar disorder and avoid antidepressant-induced manic switching. Once unipolar depression is confirmed, a first-line agent (such as an SSRI) is initiated. Because these medications take time to alter receptor sensitivity and promote neurogenesis, a 4 to 6 week trial is necessary to accurately assess clinical efficacy. Only after this trial period is completed and deemed inadequate should the physician escalate therapy by augmenting the current medication or switching to an alternative agent.
Adım Adım Çözüm
Anahtar Kavram
The foundational stepped-care management of Major Depressive Disorder requires ruling out bipolar disorder prior to initiating a first-line antidepressant, followed by an adequate trial period of 4 to 6 weeks before considering augmentation or switching strategies.
Tahmini Süre:1m 0s